2合1适应性设计中治疗效应的估计及其若干扩展
2合1适应性设计可将II期试验无缝扩展为III期以加速药物研发,但数据驱动的适应性决策给治疗效应估计带来挑战。本文研究了该设计及其扩展中估计的偏倚与方差,并提出偏倚校正估计量,从理论和数值角度研究其性质,为解释治疗效应估计提供指导。
要点
- 2合1适应性设计存在数据驱动适应性导致的治疗效应估计偏倚。
- 提出偏倚校正估计量并研究其理论性质。
- 为正确解释该设计的治疗效应估计提供指导。
核心结论
- 2合1适应性设计及其扩展中治疗效应估计存在偏倚与方差问题,所提偏倚校正估计量可提供解释指导。
研究设计与样本
- 方法学研究,聚焦2合1适应性设计及其若干扩展的估计问题。
主要发现
- 研究了2合1设计及其扩展中估计的偏倚和方差。
- 提出了若干偏倚校正估计量。
- 通过理论和/或数值研究进一步探讨了所提估计量的性质。
临床怎么用
- 为解释2合1适应性设计的治疗效应估计提供指导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 2-in-1 adaptive design allows seamless expansion of an ongoing Phase II trial into a Phase III trial to expedite a drug development program. Since its publication, it has generated a lot of interest. So far, most of the related research focused on type I error control. Similar to most adaptive designs, 2-in-1 design could also pose a great challenge on estimation of treatment effect due to the data-driven adaptation. In addition, the use of intermediate endpoint for interim adaptive decision-making is a less well-studied field. In this paper, we investigate the bias and variances in estimation for 2-in-1 design and some of its extensions, and propose some bias-adjusted estimators for 2-in-1 design. The properties of the proposed estimators are further studied theoretically and/or numerically, so as to provide guidance on how to interpret the estimated treatment effect of 2-in-1 design.
引用
- Li W, Bai X, Deng Q, et al. Estimation of treatment effect in 2-in-1 adaptive design and some of its extensions. Stat Med. 2021. PMID: 33723865. doi:10.1002/sim.8917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。